BAVA Bavarian Nordic A/S

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, September 1, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameHenrik Juuel
2.Reason for the notification
a)Position/statusExecutive Vice President and Chief Financial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transactionPurchase
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 149.563,375
d)Aggregated information
  • Aggregated volume
  • Price
 



3,375

DKK 504,775.55
e)Date of the transaction2023-09-01
f)Place of the transactionNasdaq Copenhagen A/S, XCSE

About Bavarian Nordic

Bavarian Nordic is a fully integrated vaccines company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit .

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel:

US: Graham Morrell, Paddock Circle Advisors, , Tel:

Company Announcement no. 33 / 2023

Attachment



EN
01/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Konsortium bestående af Nordic Capital og Permira reducerer minimumsbe...

Konsortium bestående af Nordic Capital og Permira reducerer minimumsbetingelsen for accept til 66 2/3% i forhold til overtagelsestilbuddet til aktionærerne i Bavarian Nordic MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF DE RELEVANTE LOVE ELLER FORORDNINGER I DEN PÅGÆLDENDE JURISDIKTION København, Danmark, 21. oktober 2025 – Med henvisning til selskabsmeddelelsen af 26. august 2025 (nr. 24/2025) angående offentliggørelsen af tilbudsdokumentet, som ændret ved  tillæggene dateret henholds...

 PRESS RELEASE

Consortium consisting of Nordic Capital and Permira lowers the minimum...

Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, October 21, 2025 – With reference to the announcement of 26 August 2025 (no. 24/2025) regarding the publication of the offer document, as amended by the supplements dated 29 September 2025 and 15 October...

 PRESS RELEASE

Bestyrelsen fastholder anbefaling i supplerende redegørelse vedrørende...

Bestyrelsen fastholder anbefaling i supplerende redegørelse vedrørende forbedret overtagelsestilbud til aktionærerne i Bavarian Nordic fra konsortium ledet af Nordic Capital og Permira MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF DE RELEVANTE LOVE ELLER FORORDNINGER I DEN PÅGÆLDENDE JURISDIKTION København, Danmark, 16. oktober, 2025 – Der henvises til Bavarian Nordic A/S' ("Bavarian Nordic" eller "Selskabet") selskabsmeddelelser af 26. august 2025 (nr. 24/2025 og nr. 25/2025) vedrøre...

 PRESS RELEASE

The Board of Directors maintains its recommendation in supplementary s...

The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, October 16, 2025 – Reference is made to Bavarian Nordic A/S' ("Bavarian Nordic" or the "Company") announcements of 26 August 2025 (no. 24/2025 and no. 25/2025) re...

 PRESS RELEASE

Konsortium bestående af Nordic Capital og Permira forhøjer tilbudspris...

Konsortium bestående af Nordic Capital og Permira forhøjer tilbudsprisen og forlænger tilbudsperioden til den 5. november 2025 i forhold til overtagelsestilbuddet til aktionærerne i Bavarian Nordic MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF DE RELEVANTE LOVE ELLER FORORDNINGER I DEN PÅGÆLDENDE JURISDIKTION København, Danmark, 15 oktober 2025 – Med henvisning til selskabsmeddelelsen af 26. august 2025 (nr. 24/2025) angående offentliggørelsen af tilbudsdokumentet ("Tilbudsdokumentet")...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch